These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 20629533

  • 1. Pharmacokinetics and whole-blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU-100480 in healthy volunteers.
    Wallis RS, Jakubiec WM, Kumar V, Silvia AM, Paige D, Dimitrova D, Li X, Ladutko L, Campbell S, Friedland G, Mitton-Fry M, Miller PF.
    J Infect Dis; 2010 Sep 01; 202(5):745-51. PubMed ID: 20629533
    [Abstract] [Full Text] [Related]

  • 2. Biomarker-assisted dose selection for safety and efficacy in early development of PNU-100480 for tuberculosis.
    Wallis RS, Jakubiec W, Kumar V, Bedarida G, Silvia A, Paige D, Zhu T, Mitton-Fry M, Ladutko L, Campbell S, Miller PF.
    Antimicrob Agents Chemother; 2011 Feb 01; 55(2):567-74. PubMed ID: 21078950
    [Abstract] [Full Text] [Related]

  • 3. Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model.
    Williams KN, Stover CK, Zhu T, Tasneen R, Tyagi S, Grosset JH, Nuermberger E.
    Antimicrob Agents Chemother; 2009 Apr 01; 53(4):1314-9. PubMed ID: 19075058
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis.
    Park IN, Hong SB, Oh YM, Kim MN, Lim CM, Lee SD, Koh Y, Kim WS, Kim DS, Kim WD, Shim TS.
    J Antimicrob Chemother; 2006 Sep 01; 58(3):701-4. PubMed ID: 16857689
    [Abstract] [Full Text] [Related]

  • 5. Addition of PNU-100480 to first-line drugs shortens the time needed to cure murine tuberculosis.
    Williams KN, Brickner SJ, Stover CK, Zhu T, Ogden A, Tasneen R, Tyagi S, Grosset JH, Nuermberger EL.
    Am J Respir Crit Care Med; 2009 Aug 15; 180(4):371-6. PubMed ID: 19520903
    [Abstract] [Full Text] [Related]

  • 6. Interaction between linezolid and Mycobacterium tuberculosis in an experimental in vitro model.
    Cremades R, Rodríguez JC, Garcia-Pachón E, Galiana A, Ruiz-García M, López P, Royo G.
    APMIS; 2011 Apr 15; 119(4-5):304-8. PubMed ID: 21492231
    [Abstract] [Full Text] [Related]

  • 7. [The analysis of clinical data about the treatment of linezolid against tuberculosis].
    Nie WJ, Chu NH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug 15; 36(8):601-3. PubMed ID: 24252739
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.
    MacGowan AP.
    J Antimicrob Chemother; 2003 May 15; 51 Suppl 2():ii17-25. PubMed ID: 12730139
    [Abstract] [Full Text] [Related]

  • 9. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis--authors' response.
    Koh WJ, Shim TS.
    J Antimicrob Chemother; 2009 Nov 15; 64(5):1119-20. PubMed ID: 19744986
    [No Abstract] [Full Text] [Related]

  • 10. Comment on: Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis.
    Yew WW, Chang KC, Chau CH.
    J Antimicrob Chemother; 2009 Nov 15; 64(5):1119; author reply 1119-20. PubMed ID: 19666903
    [No Abstract] [Full Text] [Related]

  • 11. Meropenem/clavulanate and linezolid treatment for extensively drug-resistant tuberculosis.
    Dauby N, Muylle I, Mouchet F, Sergysels R, Payen MC.
    Pediatr Infect Dis J; 2011 Sep 15; 30(9):812-3. PubMed ID: 21378593
    [Abstract] [Full Text] [Related]

  • 12. SQ109 and PNU-100480 interact to kill Mycobacterium tuberculosis in vitro.
    Reddy VM, Dubuisson T, Einck L, Wallis RS, Jakubiec W, Ladukto L, Campbell S, Nacy CA.
    J Antimicrob Chemother; 2012 May 15; 67(5):1163-6. PubMed ID: 22258923
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis.
    Zhang M, Sala C, Dhar N, Vocat A, Sambandamurthy VK, Sharma S, Marriner G, Balasubramanian V, Cole ST.
    Antimicrob Agents Chemother; 2014 Jun 15; 58(6):3217-23. PubMed ID: 24663022
    [Abstract] [Full Text] [Related]

  • 14. In vitro activities of PNU-100480 and linezolid against drug-susceptible and drug-resistant Mycobacterium tuberculosis isolates.
    Yip PC, Kam KM, Lam ET, Chan RC, Yew WW.
    Int J Antimicrob Agents; 2013 Jul 15; 42(1):96-7. PubMed ID: 23684005
    [No Abstract] [Full Text] [Related]

  • 15. Activities of several novel oxazolidinones against Mycobacterium tuberculosis in a murine model.
    Cynamon MH, Klemens SP, Sharpe CA, Chase S.
    Antimicrob Agents Chemother; 1999 May 15; 43(5):1189-91. PubMed ID: 10223934
    [Abstract] [Full Text] [Related]

  • 16. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis.
    Nam HS, Koh WJ, Kwon OJ, Cho SN, Shim TS.
    Int J Antimicrob Agents; 2009 Jan 15; 33(1):92-3. PubMed ID: 18789655
    [No Abstract] [Full Text] [Related]

  • 17. Linezolid.
    Tuberculosis (Edinb); 2008 Mar 15; 88(2):122-5. PubMed ID: 18486048
    [No Abstract] [Full Text] [Related]

  • 18. Post-antibiotic effects of linezolid and other agents against Mycobacterium tuberculosis.
    Hui M, Au-Yeang C, Wong KT, Chan CY, Yew WW, Leung CC.
    Int J Antimicrob Agents; 2008 Apr 15; 31(4):395-6. PubMed ID: 18272351
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
    Stein GE, Schooley SL, Peloquin CA, Kak V, Havlichek DH, Citron DM, Tyrrell KL, Goldstein EJ.
    Ann Pharmacother; 2005 Mar 15; 39(3):427-32. PubMed ID: 15701775
    [Abstract] [Full Text] [Related]

  • 20. In vitro susceptibility of Mycobacterium tuberculosis clinical isolates to garenoxacin and DA-7867.
    Vera-Cabrera L, Castro-Garza J, Rendon A, Ocampo-Candiani J, Welsh O, Choi SH, Blackwood K, Molina-Torres C.
    Antimicrob Agents Chemother; 2005 Oct 15; 49(10):4351-3. PubMed ID: 16189119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.